Published in Medical Device Law Weekly, March 4th, 2007
Stratagene has agreed to pay Third Wave $10.75 million in cash as full satisfaction for the judgment.
The companies also have agreed to stay any further litigation for 9 months. The companies will either seek dismissal without prejudice or an extension of the trial date for Stratagene's lawsuit against Third Wave in U.S. District Court in Delaware.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.